Trial Outcomes & Findings for Cardiometabolic Benefits of Potatoes Mediated Along the Gut-Vessel Axis in Adults With Metabolic Syndrome (NCT NCT03624569)
NCT ID: NCT03624569
Last Updated: 2025-06-15
Results Overview
Fasting serum endotoxin concentration
COMPLETED
NA
32 participants
Day 14
2025-06-15
Participant Flow
Participant milestones
| Measure |
Bagel Diet First and Potato Diet
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment). After a washout period of 2 weeks, they then received an identical diet for 2-weeks that contained potatoes instead of bagels (comparator arm).
|
Potato Diet First and Bagel Diet
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato. After a washout period of 2 weeks, they then received an identical diet for 2-weeks that contained bagels instead of a potatoes (comparator arm).
|
|---|---|---|
|
First Intervention (2 Weeks)
STARTED
|
20
|
12
|
|
First Intervention (2 Weeks)
COMPLETED
|
19
|
10
|
|
First Intervention (2 Weeks)
NOT COMPLETED
|
1
|
2
|
|
Washout (2 Weeks)
STARTED
|
19
|
10
|
|
Washout (2 Weeks)
COMPLETED
|
19
|
10
|
|
Washout (2 Weeks)
NOT COMPLETED
|
0
|
0
|
|
Second Intervention (2 Weeks)
STARTED
|
19
|
10
|
|
Second Intervention (2 Weeks)
COMPLETED
|
18
|
9
|
|
Second Intervention (2 Weeks)
NOT COMPLETED
|
1
|
1
|
Reasons for withdrawal
| Measure |
Bagel Diet First and Potato Diet
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment). After a washout period of 2 weeks, they then received an identical diet for 2-weeks that contained potatoes instead of bagels (comparator arm).
|
Potato Diet First and Bagel Diet
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato. After a washout period of 2 weeks, they then received an identical diet for 2-weeks that contained bagels instead of a potatoes (comparator arm).
|
|---|---|---|
|
First Intervention (2 Weeks)
Withdrawal by Subject
|
1
|
2
|
|
Second Intervention (2 Weeks)
Protocol Violation
|
1
|
1
|
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Baseline Measures - All Participants
n=27 Participants
Baseline Measures of All Participants Prior To Randomization
|
|---|---|
|
Age, Continuous
|
32.5 years
STANDARD_DEVIATION 6.8 • n=27 Participants
|
|
Sex: Female, Male
Female
|
14 Participants
n=27 Participants
|
|
Sex: Female, Male
Male
|
13 Participants
n=27 Participants
|
|
Region of Enrollment
United States
|
27 participants
n=27 Participants
|
|
Body mass index (kg/m^2)
|
35 kg/m^2
STANDARD_DEVIATION 5.1 • n=27 Participants
|
|
Waist Circumference (cm)
|
109.8 cm
STANDARD_DEVIATION 12.2 • n=27 Participants
|
|
Systolic Blood Pressure (mmHg)
|
120.5 mmHg
STANDARD_DEVIATION 8.4 • n=27 Participants
|
|
Diastolic Blood Pressure (mmHg)
|
82.9 mmHg
STANDARD_DEVIATION 5.6 • n=27 Participants
|
|
Plasma Glucose (mg/dl)
|
103.7 mg/dL
STANDARD_DEVIATION 8.1 • n=27 Participants
|
|
Plasma High-density Lipoprotein-Cholesterol (mg/dl)
|
36.7 mg/dL
STANDARD_DEVIATION 7.4 • n=27 Participants
|
|
Plasma Triglyceride (mg/dl)
|
127.6 mg/dL
STANDARD_DEVIATION 80.4 • n=27 Participants
|
|
Plasma Ascorbic Acid (umol/L)
|
40.4 umol/L
STANDARD_DEVIATION 21.2 • n=27 Participants
|
PRIMARY outcome
Timeframe: Day 14Fasting serum endotoxin concentration
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Endotoxin
|
21.2 EU/mL
Standard Deviation 3.0
|
23.3 EU/mL
Standard Deviation 3.0
|
PRIMARY outcome
Timeframe: Day 14 Postprandial (0, 30, 60, 90, 120 minutes)Area under curve (change from baseline) for brachial artery flow-mediated dilation (FMD). The unit for FMD is %, which is calculated as: \[vessel diameter in millimeters (post-occlusion) - vessel diameter in millimeters (pre-occlusion)\] / vessel diameter in millimeters (pre-occlusion) x 100. FMD(%) is then used to caluclate area under the curve based on independent measures of FMD at 0-120 minutes)
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Vascular Endothelial Function
|
-259 % x min
Standard Error 75
|
-198 % x min
Standard Error 71
|
SECONDARY outcome
Timeframe: Fasting glucose on Day 0Fasting plasma glucose
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Fasting Glucose Day 0
|
104 mg/dL
Standard Deviation 13.5
|
109.5 mg/dL
Standard Deviation 14.6
|
SECONDARY outcome
Timeframe: Fasting glucose on Day 14Fasting plasma glucose Day 14
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Fasting Glucose Day 14
|
101.9 mg/dL
Standard Deviation 12.3
|
102.3 mg/dL
Standard Deviation 13.5
|
SECONDARY outcome
Timeframe: Fasting insulin on Day 0Fasting plasma insulin
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Fasting Insulin Day 0
|
21.1 uIU/mL
Standard Error 5.5
|
17.0 uIU/mL
Standard Error 2.0
|
SECONDARY outcome
Timeframe: Fasting insulin on Day 14Fasting plasma insulin Day 14
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Fasting Insulin Day 14
|
14.2 uIU/mL
Standard Error 2.0
|
14.9 uIU/mL
Standard Error 2.4
|
SECONDARY outcome
Timeframe: Day 14 postprandial (0, 30, 60, 90, 120 minutes)Plasma insulin concentration area under curve change from baseline
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Postprandial Insulin
|
5940 uIU/mL x min
Standard Error 670
|
7086 uIU/mL x min
Standard Error 1372
|
SECONDARY outcome
Timeframe: Day 14 postprandial (0, 30, 60, 90, 120 minutes)Postprandial plasma glucose concentration area under curve change from baseline
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Postprandial Glucose
|
2649 mg/dL x min
Standard Error 499
|
2808 mg/dL x min
Standard Error 565
|
SECONDARY outcome
Timeframe: Day 0Fasting serum endotoxin concentration
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Fasting Endotoxin
|
26.6 EU/mL
Standard Error 2.0
|
22.3 EU/mL
Standard Error 2.1
|
SECONDARY outcome
Timeframe: Day 14 postprandial (0, 30, 60, 90, 120 minutes)Postprandial serum endotoxin concentration area under curve change from baseline
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Postprandial Endotoxin
|
450 EU/ml x min
Standard Error 249
|
-120 EU/ml x min
Standard Error 176
|
SECONDARY outcome
Timeframe: Day 14, 0-5 hours post-consumption of sugar probesUrinary concentration of the non-digestible sugars lactulose/mannitol (mg/mg)
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Lactulose/Mannitol Ratio
|
.154 Ratio (mg/mg)
Standard Error .013
|
.151 Ratio (mg/mg)
Standard Error 0.1
|
SECONDARY outcome
Timeframe: Day 14, 6-24 hours post-consumption of sugar probesUrinary concentration of the non-digestible sugars sucralose/erythritol
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Sucralose/Erythritol Ratio
|
.0148 Ratio (mg/mg)
Standard Error 0.002
|
0.01667 Ratio (mg/mg)
Standard Error 0.001925
|
SECONDARY outcome
Timeframe: Day 14Fecal concentration of butyrate
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Fecal Butyrate
|
21.3 umol/g
Standard Error 2.7
|
17.9 umol/g
Standard Error 2.6
|
SECONDARY outcome
Timeframe: Day 14Fecal concentration of acetate
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Fecal Acetate
|
52.3 umol/g
Standard Error 4.7
|
46.6 umol/g
Standard Error 3.9
|
SECONDARY outcome
Timeframe: Day 14Fecal concentration of propionate
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Fecal Propionate
|
23.1 umol/g
Standard Error 2.2
|
19.3 umol/g
Standard Error 2.1
|
SECONDARY outcome
Timeframe: Day 14 postprandial (0, 30, 60, 90, 120 minutes)Plasma CCK area under curve change from baseline
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Postprandial Cholecystokinin
|
-196 pmol/L x min
Standard Error 266
|
-67 pmol/L x min
Standard Error 344
|
SECONDARY outcome
Timeframe: Day 14Fasting plasma concentration of CCK
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Fasting Cholecystokinin
|
14.3 pmol/L
Standard Error 3.1
|
14.2 pmol/L
Standard Error 3.4
|
SECONDARY outcome
Timeframe: Day 14 postprandial (0, 30, 60, 90, 120 minutes)Plasma total nitrite/nitrate area under curve change from baseline
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Postprandial NOx
|
-240 umol/L x min
Standard Error 88
|
-433 umol/L x min
Standard Error 48
|
SECONDARY outcome
Timeframe: Day 14Fasting plasma concentration of nitrite/nitrate
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Fasting NOx
|
29.8 umol/L x min
Standard Error 3.7
|
30.1 umol/L x min
Standard Error 2.3
|
SECONDARY outcome
Timeframe: Day 14 postprandial (0, 30, 60, 90, 120 minutes)Plasma MDA concentration, biomarker of oxidative stress area under curve change from baseline
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Postprandial Malondialdehyde (MDA)
|
57.2 umol/L x min
Standard Error 6.8
|
45.4 umol/L x min
Standard Error 7.2
|
SECONDARY outcome
Timeframe: Day 14Fasting plasma MDA concentration, biomarker of oxidative stress
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Fasting Malondialdehyde (MDA)
|
1.78 umol/L
Standard Error .1
|
1.93 umol/L
Standard Error .1
|
SECONDARY outcome
Timeframe: Day 14Fasting flow-mediated dilation of the brachial artery. Measure is calculated as: \[post-occlusion vessel diameter (mm) - pre-occlusion vessel diameter (mm) / pre-occlusion vessel diameter (mm)\] x 100
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Fasting Vascular Endothelial Function
|
7.2 % change in blood vessel dilation
Standard Error 1.3
|
8.7 % change in blood vessel dilation
Standard Error 1.3
|
SECONDARY outcome
Timeframe: Day 14Fasting vitamin C concentration, biomarker of oxidative stress
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Vitamin C
|
47.5 umol/L
Standard Error 2.9
|
52.5 umol/L
Standard Error 4.8
|
SECONDARY outcome
Timeframe: Day 14Carotid intima-media thickness. Mean thickness of left and right carotid artery intima media.
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
cIMT
|
0.603 mm
Standard Deviation 0.109
|
0.609 mm
Standard Deviation 0.114
|
SECONDARY outcome
Timeframe: Day 14Body mass index calculated as kg weight per meters squared
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Day 14 BMI
|
35.1 kg/m^2
Standard Error 1.1
|
35.2 kg/m^2
Standard Error 1.1
|
SECONDARY outcome
Timeframe: Day 0Waist circumference in centimeters
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Day 0 Waist Circumference
|
108.5 cm
Standard Error 2.2
|
119.1 cm
Standard Error 2.2
|
SECONDARY outcome
Timeframe: Day 14Waist circumference in centimeters
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Day 14 Waist Circumference
|
107.8 mmHg
Standard Error 2.4
|
107.5 mmHg
Standard Error 2.4
|
SECONDARY outcome
Timeframe: Day 0Diastolic blood pressure on Day 0
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Day 0 Diastolic Blood Pressure
|
81.5 mmHg
Standard Error 1.3
|
81.9 mmHg
Standard Error 1.5
|
SECONDARY outcome
Timeframe: Day 14Diastolic blood pressure on Day 14
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Day 14 Diastolic Blood Pressure
|
75.9 mmHg
Standard Error 1.7
|
77.7 mmHg
Standard Error 1.4
|
SECONDARY outcome
Timeframe: Day 0Systolic blood pressure on Day 0
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Day 0 Systolic Blood Pressure
|
123.1 mmHg
Standard Error 1.9
|
119.1 mmHg
Standard Error 2.2
|
SECONDARY outcome
Timeframe: Day 14Systolic blood pressure on Day 14
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Day 14 Systolic Blood Pressure
|
113.6 mmHg
Standard Error 1.9
|
114.6 mmHg
Standard Error 1.8
|
SECONDARY outcome
Timeframe: Day 0Body mass index calculated as kg weight per meters squared
Outcome measures
| Measure |
Bagel Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a bagel (comparator treatment).
|
Potato Diet
n=27 Participants
Participants were provided a prescribed eucaloric diet for 2-weeks that contained a potato.
|
|---|---|---|
|
Day 0 BMI
|
35.6 kg/m^2
Standard Error 1.2
|
35.7 kg/m^2
Standard Error 1.2
|
Adverse Events
Bagel Diet
Potato Diet
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Richard Bruno, Principal Investigator
The Ohio State University
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place